Healthcare provider profile · identity verified

Garvin Nickell, MD

Internal Medicine · MASON, OH · NPI 1861456568

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	532	153
Levothyroxine Sodium	Levothyroxine Sodium	413	107
Amlodipine Besylate	Amlodipine Besylate	325	87
Tamsulosin Hcl	Tamsulosin Hcl	229	63
Lisinopril	Lisinopril	213	58
Metformin Hcl Er	Metformin Hcl	181	52
Losartan Potassium	Losartan Potassium	150	45
Metoprolol Succinate	Metoprolol Succinate	148	47
Simvastatin	Simvastatin	134	37
Omeprazole	Omeprazole	131	42
Hydrochlorothiazide	Hydrochlorothiazide	122	37
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	111	27
Trazodone Hcl	Trazodone Hcl	111	31
Meloxicam	Meloxicam	107	36
Metformin Hcl	Metformin Hcl	101	30
Pantoprazole Sodium	Pantoprazole Sodium	99	34
Rosuvastatin Calcium	Rosuvastatin Calcium	98	33
Pravastatin Sodium	Pravastatin Sodium	92	25
Gabapentin	Gabapentin	91	34
Metoprolol Tartrate	Metoprolol Tartrate	80	20
Furosemide	Furosemide	76	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Olmesartan Medoxomil	Olmesartan Medoxomil	68	15
Allopurinol	Allopurinol	67	16
Alprazolam	Alprazolam	67	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	65	14
Montelukast Sodium	Montelukast Sodium	64	19
Duloxetine Hcl	Duloxetine Hcl	62	14
Eliquis	Apixaban	62	17
Januvia	Sitagliptin Phosphate	62	14
Ozempic	Semaglutide	59	suppressed
Citalopram Hbr	Citalopram Hydrobromide	58	14
Fluticasone Propionate	Fluticasone Propionate	58	18
Trulicity	Dulaglutide	58	suppressed
Methylprednisolone	Methylprednisolone	57	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	54	17
Clonazepam	Clonazepam	50	13
Lorazepam	Lorazepam	50	suppressed
Glimepiride	Glimepiride	48	12
Amitriptyline Hcl	Amitriptyline Hcl	47	12
Amoxicillin	Amoxicillin	46	34
Warfarin Sodium	Warfarin Sodium	46	suppressed
Atenolol	Atenolol	44	14
Sertraline Hcl	Sertraline Hcl	43	14
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Azithromycin	Azithromycin	41	39
Jardiance	Empagliflozin	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	13
Carvedilol	Carvedilol	38	suppressed
Topiramate	Topiramate	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	13
Memantine Hcl	Memantine Hcl	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	32
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Potassium Chloride	Potassium Chloride	33	12
Xarelto	Rivaroxaban	33	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Ezetimibe	Ezetimibe	30	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Prednisone	Prednisone	29	25
Lovastatin	Lovastatin	28	suppressed
Famotidine	Famotidine	25	11
Finasteride	Finasteride	25	suppressed
Pregabalin	Pregabalin	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Naproxen	Naproxen	20	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Carisoprodol	Carisoprodol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Diazepam	Diazepam	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Glipizide Er	Glipizide	15	suppressed
Ketoconazole	Ketoconazole	15	11
Temazepam	Temazepam	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Valsartan	Valsartan	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Glipizide	Glipizide	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Ramipril	Ramipril	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error